Drugs / LX201
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT00447187 | Apr 2007 → Mar 2009 | corneal disorder | Lux Biosciences, Inc. | Terminated | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | LX201 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00447187 ↗ |
| Route | Other | “LX201 was intended for surgical episcleral placement in the eye.” NCT00447187 ↗ |